학술논문
The prostate-specific membrane antigen holds potential as a vascular target for endogenous radiotherapy with [177 Lu]Lu-PSMA-I&T for triple-negative breast cancer.
Document Type
Article
Author
Source
Breast Cancer Research; 2/20/2024, Vol. 26 Issue 1, p1-11, 11p
Subject
Language
ISSN
14655411
Abstract
Copyright of Breast Cancer Research is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)